Skip to main content
FinSpry Logo
FinSpry
MXCT logo
MXCT
(NASDAQ)
MaxCyte, Inc.
$1.13-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

MaxCyte (MXCT) Stock Price & Financial Analysis

MaxCyte Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.12 - $1.16
52-Week High$2.37
52-Week Low$0.64
Open$1.14
Volume332.46K
Average Volume (3M)1.08M
Market Cap120.77M
Shares Outstanding106.88M
Price to Sales (P/S)3.74
Price to Book (P/B)0.72
EV/EBITDA-3.79
Revenue (TTM)32.29M
Net Income (TTM)-39.12M
Free Cash Flow (TTM)-29.50M
EPS (TTM)$-0.37
Profit Margin-121.16%
Operating Margin-121.33%
Return on Equity (ROE)-23.30%
Debt to Equity0.10
50-Day MA$0.98
200-Day MA$1.21
52-Week Change-47.44%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About MaxCyte

What is the current stock price for MXCT?

As of the latest trading session, MXCT stock trades at $1.13. The 52-week range is $0.64–$2.37, with a day range of $1.12–$1.16.

What is the P/E ratio for MXCT?

The P/E ratio (Price-to-Earnings) for MXCT is shown in the Key Statistics section. This valuation metric helps compare MaxCyte, Inc. to industry peers.

Does MXCT pay dividends?

MaxCyte does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for MXCT?

Based on 5 analysts, the consensus for MXCT is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of MXCT?

MaxCyte's market capitalization is $120.8M, classifying it as a micro-cap company. MaxCyte operates in the Healthcare sector within the Medical Devices industry.